advanced esophageal cancer

基本解釋

Objective To evaluate the response rate and tolerance in patients with advanced esophageal cancer who were treated with thalidomide plus concurrent chemoradiotherapy.
目的評價(jià)沙利度胺聯(lián)合同步放化療治療局部中晚期食管癌的臨床療效和耐受性。
Conclusion Implantation of 125I seeds combined with esophageal intraluminal stents may prolong survival time and improve QOL of patients with advanced esophageal cancer.
目的通過觀察125I粒子食管支架對晚期食管癌患者的生存期及生活質(zhì)量的影響從而評價(jià)其療效。
Conclusion sequential chemotherapy to radiotherapy in the treatment of advanced esophageal cancer than radiotherapy alone can increase the CR rate, extended survival time.
結(jié)論序貫化放療治療中晚期食管癌較單純放療能提高CR率，延長生存期。
www.cmed.org.cn

晚期食管癌
From Jan. 1978 to Oct. 1983, 1853 patients with advanced esophageal cancer were treatedby radiotherapy. All the cases were confirmed by pathology.
1978年1月至1983年10月對病理證實(shí)、資料完整而首次收治的中、晚期食管癌1853例施行了單純放療，其中存活10年以上的110例，生存率為5．9％。